Skip to main content

Table 4 Most frequent serious side effects noted during the study (n)

From: Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: A sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients

Reported Side Effects Irbesartan Irbesartan/HCTZ
1 Cardiogenic shock 1 2
2 Cerebral infarction 1 1
3 Gastrointestinal hemorrhage 1 1
4 Metastatic bronchial carcinoma 1 1
5 Myocardial infarction 2 1
6 Rash 1 1
7 Tachyarrhythmia 1 1
8 Vertigo 1 1
  1. out of a total of 14,200 patients